Midday Gainers In Depth

Announcement that it was acquired by Israeli peer Nice-Systems Ltd (ADR) (NASDAQ: NICE) for $940 million

Initiating clinical trial for Bordatella and application to the FDA for direct test in Q4 of this year

Phil Falcone's HC2 Holdings Inc (NYSE: HCHC) offers takeover bid

Related Link: Mid-Day Market Update: US Stocks Turn Higher; Target Shares Slide

Announced strategic alliance with SAP

Reported Q1 loss, but positive sentiment still high

Entered collaboration and license agreement with Janssen to develop new DART Molecule for treatment of cancer

Medtronic PLC (NYSE: MDT) enters into agreements with Mazor Robotics for take over

Positive sentiment on the stock despite sluggish sentiment in the sector

Even though it breached 50-day moving average in a bearish way

Update on clinical trials "comeback time for Macrocure Ltd"